Loading clinical trials...
Loading clinical trials...
This study is being done to see if the blood pressure lowering effect of an approved drug nebivolol is comparable to that of another approved drug carvedilol for the treatment of hypertension in patie...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Forest Laboratories
NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more
NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease
NCT06647511 · Gestational Hypertension
NCT07439939 · Liver Cirrhosis, Portal Hypertension
NCT05746039 · Obesity, Interstitial Lung Disease, and more
Forest Investigative Site
Birmingham, Alabama
Forest Investigative Site
Peoria, Arizona
Forest Investigative Site
Buena Park, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions